Vivo introduces the S50t Vitality Edition, a mid-range smartphone featuring a Snapdragon 8s Gen 3 chip, 50MP camera system, and a 6.5Ah battery, but remains exclusive to China for now, offering premium specs at a lower price point.
Vivo has added a new mid-range handset to its S50 line-up, but for now the Vivo S50t Vitality Edition is a China-only launch. The company is positioning it as a lower-cost alternative to the standard S50, with the key trade-off appearing to be slower UFS 3.1 storage in place of the faster UFS 4.1 found on the main model, according to coverage by MobileMasr and OBNews. Vivo has not given any indication yet that the device will reach international markets.
The phone is built around Qualcomm’s Snapdragon 8s Gen 3, a chip that sits below the company’s current flagship platform but is still aimed at performance-focused mid-range devices. It is paired with a 6.59-inch AMOLED panel at 2,750 x 1,260 pixels and a 120Hz refresh rate, giving the handset specifications that are closer to premium territory than to entry-level mid-range rivals, according to Notebookcheck and the device listings compiled by Mobolist and Gizmochina.
Camera hardware is another clear selling point. Vivo has fitted the S50t Vitality Edition with a 50-megapixel main camera, an 8-megapixel ultra-wide lens and a 50-megapixel periscope telephoto camera with 3x optical zoom. The front camera is also rated at 50 megapixels, making the device unusually ambitious for selfies as well as rear-camera use, according to the same sources.
Battery life and charging should also be competitive. The handset carries a 6,500mAh battery and supports 90W wired charging, while wireless charging is not included. Vivo is offering the phone in several colour options and in at least two memory configurations, with the base version listed at the equivalent of roughly €385 in China after discount, although pricing and availability outside the domestic market remain unannounced.
Disclaimer: This content is intended for informational purposes only. Readers are advised to exercise their own judgement, conduct due diligence, or consult a qualified expert before acting on any information provided.
